Glycopyrronium Bromide inhaler
- BNF:
- 3.1
- Status:
- Grey
- Decision Date:
- June 2015
Comments
GREY 2nd line LAMA:1,2
- Seebri Breezhaler and caps (DPI) (Decision date - August 19)
Grey Drug Classifications
- 1: Lack of data on effectiveness compared with standard therapy
- 2: Lack of data on safety compared with standard therapy
search again